vs
普尔斯马特（PSMT）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是普尔斯马特的1.0倍（$1.4B vs $1.4B），瑞思迈净利率更高（27.6% vs 2.9%，领先24.7%），瑞思迈同比增速更快（11.0% vs 9.9%），瑞思迈自由现金流更多（$311.2M vs $32.6M），过去两年瑞思迈的营收复合增速更高（9.0% vs 3.5%）
PriceSmart（普尔斯马特）是一家美资会员制仓储商超运营商，业务覆盖中美洲、加勒比地区及南美洲。公司由Price Club的创立者索尔·普莱斯与罗伯特·普莱斯共同创办，罗伯特·普莱斯现任董事会主席。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
PSMT vs RMD — 直观对比
营收规模更大
RMD
是对方的1.0倍
$1.4B
营收增速更快
RMD
高出1.1%
9.9%
净利率更高
RMD
高出24.7%
2.9%
自由现金流更多
RMD
多$278.6M
$32.6M
两年增速更快
RMD
近两年复合增速
3.5%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.4B |
| 净利润 | $40.2M | $392.6M |
| 毛利率 | 17.7% | 61.8% |
| 营业利润率 | 4.6% | 34.6% |
| 净利率 | 2.9% | 27.6% |
| 营收同比 | 9.9% | 11.0% |
| 净利润同比 | 7.3% | 13.9% |
| 每股收益（稀释后） | $1.29 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PSMTRMD
| Q4 25 | $1.4B | $1.4B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $1.3B | $1.3B | ||
| Q1 25 | $1.4B | $1.3B | ||
| Q4 24 | $1.3B | $1.3B | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $1.2B | $1.2B | ||
| Q1 24 | $1.3B | $1.2B |
净利润PSMTRMD
| Q4 25 | $40.2M | $392.6M | ||
| Q3 25 | $31.5M | $348.5M | ||
| Q2 25 | $35.2M | $379.7M | ||
| Q1 25 | $43.8M | $365.0M | ||
| Q4 24 | $37.4M | $344.6M | ||
| Q3 24 | $29.1M | $311.4M | ||
| Q2 24 | $32.5M | $292.2M | ||
| Q1 24 | $39.3M | $300.5M |
毛利率PSMTRMD
| Q4 25 | 17.7% | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | 17.1% | 59.3% | ||
| Q4 24 | 17.4% | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率PSMTRMD
| Q4 25 | 4.6% | 34.6% | ||
| Q3 25 | 4.0% | 33.4% | ||
| Q2 25 | 4.3% | 33.7% | ||
| Q1 25 | 4.8% | 33.0% | ||
| Q4 24 | 4.6% | 32.5% | ||
| Q3 24 | 4.0% | 31.6% | ||
| Q2 24 | 4.1% | 31.2% | ||
| Q1 24 | 4.9% | 31.3% |
净利率PSMTRMD
| Q4 25 | 2.9% | 27.6% | ||
| Q3 25 | 2.4% | 26.1% | ||
| Q2 25 | 2.7% | 28.2% | ||
| Q1 25 | 3.2% | 28.3% | ||
| Q4 24 | 3.0% | 26.9% | ||
| Q3 24 | 2.4% | 25.4% | ||
| Q2 24 | 2.6% | 23.9% | ||
| Q1 24 | 3.0% | 25.1% |
每股收益（稀释后）PSMTRMD
| Q4 25 | $1.29 | $2.68 | ||
| Q3 25 | $1.02 | $2.37 | ||
| Q2 25 | $1.14 | $2.58 | ||
| Q1 25 | $1.45 | $2.48 | ||
| Q4 24 | $1.21 | $2.34 | ||
| Q3 24 | $0.94 | $2.11 | ||
| Q2 24 | $1.08 | $1.97 | ||
| Q1 24 | $1.31 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $320.6M | $1.4B |
| 总债务越低越好 | $180.3M | $403.9M |
| 股东权益账面价值 | $1.3B | $6.3B |
| 总资产 | $2.4B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.14× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资PSMTRMD
| Q4 25 | $320.6M | $1.4B | ||
| Q3 25 | $314.2M | $1.4B | ||
| Q2 25 | $262.4M | $1.2B | ||
| Q1 25 | $247.3M | $932.7M | ||
| Q4 24 | $222.2M | $521.9M | ||
| Q3 24 | $225.5M | $426.4M | ||
| Q2 24 | $228.2M | $238.4M | ||
| Q1 24 | $264.2M | $237.9M |
总债务PSMTRMD
| Q4 25 | $180.3M | $403.9M | ||
| Q3 25 | $186.6M | $408.7M | ||
| Q2 25 | $103.1M | $658.4M | ||
| Q1 25 | $107.1M | $663.1M | ||
| Q4 24 | $115.6M | $662.9M | ||
| Q3 24 | $130.4M | $667.6M | ||
| Q2 24 | $135.1M | $697.3M | ||
| Q1 24 | $140.0M | $997.0M |
股东权益PSMTRMD
| Q4 25 | $1.3B | $6.3B | ||
| Q3 25 | $1.2B | $6.1B | ||
| Q2 25 | $1.2B | $6.0B | ||
| Q1 25 | $1.2B | $5.5B | ||
| Q4 24 | $1.2B | $5.3B | ||
| Q3 24 | $1.1B | $5.2B | ||
| Q2 24 | $1.1B | $4.9B | ||
| Q1 24 | $1.1B | $4.6B |
总资产PSMTRMD
| Q4 25 | $2.4B | $8.5B | ||
| Q3 25 | $2.3B | $8.3B | ||
| Q2 25 | $2.1B | $8.2B | ||
| Q1 25 | $2.1B | $7.6B | ||
| Q4 24 | $2.1B | $7.1B | ||
| Q3 24 | $2.0B | $7.2B | ||
| Q2 24 | $2.0B | $6.9B | ||
| Q1 24 | $2.0B | $6.8B |
负债/权益比PSMTRMD
| Q4 25 | 0.14× | 0.06× | ||
| Q3 25 | 0.15× | 0.07× | ||
| Q2 25 | 0.08× | 0.11× | ||
| Q1 25 | 0.09× | 0.12× | ||
| Q4 24 | 0.10× | 0.13× | ||
| Q3 24 | 0.12× | 0.13× | ||
| Q2 24 | 0.12× | 0.14× | ||
| Q1 24 | 0.13× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $71.2M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $32.6M | $311.2M |
| 自由现金流率自由现金流/营收 | 2.4% | 21.9% |
| 资本支出强度资本支出/营收 | 2.8% | 2.0% |
| 现金转化率经营现金流/净利润 | 1.77× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $125.5M | $1.8B |
8季度趋势，按日历期对齐
经营现金流PSMTRMD
| Q4 25 | $71.2M | $339.7M | ||
| Q3 25 | $82.1M | $457.3M | ||
| Q2 25 | $52.8M | $538.8M | ||
| Q1 25 | $87.9M | $578.7M | ||
| Q4 24 | $38.5M | $308.6M | ||
| Q3 24 | $41.8M | $325.5M | ||
| Q2 24 | $38.1M | $440.1M | ||
| Q1 24 | $86.6M | $402.0M |
自由现金流PSMTRMD
| Q4 25 | $32.6M | $311.2M | ||
| Q3 25 | $25.6M | $414.4M | ||
| Q2 25 | $14.0M | $508.2M | ||
| Q1 25 | $53.2M | $557.9M | ||
| Q4 24 | $10.3M | $288.0M | ||
| Q3 24 | $15.2M | $307.7M | ||
| Q2 24 | $-308.0K | $415.2M | ||
| Q1 24 | $16.4M | $380.8M |
自由现金流率PSMTRMD
| Q4 25 | 2.4% | 21.9% | ||
| Q3 25 | 1.9% | 31.0% | ||
| Q2 25 | 1.1% | 37.7% | ||
| Q1 25 | 3.9% | 43.2% | ||
| Q4 24 | 0.8% | 22.5% | ||
| Q3 24 | 1.2% | 25.1% | ||
| Q2 24 | -0.0% | 33.9% | ||
| Q1 24 | 1.3% | 31.8% |
资本支出强度PSMTRMD
| Q4 25 | 2.8% | 2.0% | ||
| Q3 25 | 4.2% | 3.2% | ||
| Q2 25 | 2.9% | 2.3% | ||
| Q1 25 | 2.5% | 1.6% | ||
| Q4 24 | 2.2% | 1.6% | ||
| Q3 24 | 2.2% | 1.5% | ||
| Q2 24 | 3.1% | 2.0% | ||
| Q1 24 | 5.4% | 1.8% |
现金转化率PSMTRMD
| Q4 25 | 1.77× | 0.87× | ||
| Q3 25 | 2.60× | 1.31× | ||
| Q2 25 | 1.50× | 1.42× | ||
| Q1 25 | 2.01× | 1.59× | ||
| Q4 24 | 1.03× | 0.90× | ||
| Q3 24 | 1.44× | 1.05× | ||
| Q2 24 | 1.17× | 1.51× | ||
| Q1 24 | 2.20× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PSMT
| Fresh Foods | $454.9M | 33% |
| Caribbean Operations Segment | $396.5M | 29% |
| Colombia Operations Segment | $204.1M | 15% |
| Hardlines | $162.6M | 12% |
| Softlines | $99.8M | 7% |
| ship Income Member | $24.5M | 2% |
| Health Services | $14.5M | 1% |
| Other Revenue And Income | $4.2M | 0% |
| United States Operations Segment | $510.0K | 0% |
| Export Sales | $359.0K | 0% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
